中华实验和临床感染病杂志(电子版)
中華實驗和臨床感染病雜誌(電子版)
중화실험화림상감염병잡지(전자판)
CHINESE JOURNAL OF EXPERIMENTAL AND CLINICAL INFECTIOUS DISEASES(ELECTRONIC VERSION)
2014年
2期
214-216
,共3页
蓝峰%刘红蓓%陈芳%潘祺
藍峰%劉紅蓓%陳芳%潘祺
람봉%류홍배%진방%반기
冠心病%肺部感染%雾化%痰热清注射液
冠心病%肺部感染%霧化%痰熱清註射液
관심병%폐부감염%무화%담열청주사액
Coronary heart disease%Pulmonary infection%Spray inhalation%Tanreqing injection
目的:观察分析雾化法联合痰热清注射液治冠心病并发肺部感染的临床疗效。方法选取2010年2月至2012年12月本院收治的100例冠心病并发肺部感染患者,随机分成治疗组和对照组各50例。治疗组在冠心病常规治疗上雾化法联合痰热清注射液治疗,对照组在常规治疗基础上给予雾化法治疗,比较两组患者治疗前后肺部体征,判断治疗有效率,观察患者心率变化以及心绞痛发生情况。结果治疗组患者显效35例,有效12例,无效3例,总有效率为94%,优于对照组(总有效率为78.0%),组间总有效率比较差异具有统计学意义(χ2=10.12,P<0.05)。结论雾化法联合痰热清注射液治冠心病并发肺部感染可有效地提高患者的治愈率,减少患者心绞痛次数,值得临床上推广应用。
目的:觀察分析霧化法聯閤痰熱清註射液治冠心病併髮肺部感染的臨床療效。方法選取2010年2月至2012年12月本院收治的100例冠心病併髮肺部感染患者,隨機分成治療組和對照組各50例。治療組在冠心病常規治療上霧化法聯閤痰熱清註射液治療,對照組在常規治療基礎上給予霧化法治療,比較兩組患者治療前後肺部體徵,判斷治療有效率,觀察患者心率變化以及心絞痛髮生情況。結果治療組患者顯效35例,有效12例,無效3例,總有效率為94%,優于對照組(總有效率為78.0%),組間總有效率比較差異具有統計學意義(χ2=10.12,P<0.05)。結論霧化法聯閤痰熱清註射液治冠心病併髮肺部感染可有效地提高患者的治愈率,減少患者心絞痛次數,值得臨床上推廣應用。
목적:관찰분석무화법연합담열청주사액치관심병병발폐부감염적림상료효。방법선취2010년2월지2012년12월본원수치적100례관심병병발폐부감염환자,수궤분성치료조화대조조각50례。치료조재관심병상규치료상무화법연합담열청주사액치료,대조조재상규치료기출상급여무화법치료,비교량조환자치료전후폐부체정,판단치료유효솔,관찰환자심솔변화이급심교통발생정황。결과치료조환자현효35례,유효12례,무효3례,총유효솔위94%,우우대조조(총유효솔위78.0%),조간총유효솔비교차이구유통계학의의(χ2=10.12,P<0.05)。결론무화법연합담열청주사액치관심병병발폐부감염가유효지제고환자적치유솔,감소환자심교통차수,치득림상상추엄응용。
Objective Observe and analyze the clinical effects of spray inhalation combined with Tanreqing injection in treatment of patients with coronary heart disease combined effect of pulmonary infection. Methods Total of 100 patients with coronary heart disease combined effect of pulmonary infection were randomly divided into two groups (50 cases each group), treated group were given spray inhalation combined with Tanreqing injection based with general treatment, control group for spray inhalation, and the clinical effects after treatment were compared. Results The total effective rate of treatment group was 94%, which was higher than that in control group (78.0%), with signiifcant difference (χ2=10.12, P<0.05). Conclusions The atomization method combined Tanreqing concurrent for the treatment of coronary heart disease in patients with lung infection could effectively improve the cure rate and reduce the number of patients with angina which should be widely applied in clinical.